Vindhyachal Expressway - Business-News-Today.com

Business-News-Today.com

Business news, market intelligence, and global industry analysis.

Business-News-Today.com

The Latest

Oxford Biomedica (LSE: OXB) delivers first EBITDA profit as revenue surges 33% and BMS CAR-T deal signals commercial maturity

Representative image of AI-driven central nervous system drug discovery, reflecting how Insilico Medicine expanded its Tenacia Biotechnology collaboration in a deal worth up to $94.75 million.

Insilico Medicine just doubled down on CNS with Tenacia. Here’s why that matters now.

Ola Electric’s #EndICEAge campaign slashes entry price to Rs 49,999 to reclaim lost ground in India’s electric two-wheeler market

NEXT plc (LON: NXT) delivers record profit of £1.16bn as international surge and brand portfolio drive 17% EPS growth

Read More

5 minute read

General business news

Kalpataru Projects (NSE: KPIL) exits Vindhyachal Expressway SPV in Rs 775cr deal with Actis

Kalpataru sells Vindhyachal Expressway SPV to Actis for Rs 775 crore. Find out what this move signals about the company’s capital strategy in 2026.

January 17, 2026

web analytics